We’re thrilled to share that our CEO and co-founder, Levana Sani, recently took part in “Tech A Look”, a segment by CNBC Indonesia, to discuss a forward-thinking topic: “The Future of AI in Healthcare”. During the segment, Levana highlighted how we at Nalagenetics are incorporating AI into the innovation behind genetic testing to revolutionize healthcare in Indonesia. 🌐

She also shared insights about our newest product, CardiacReady™, a preventive tool designed to assess the risk of cardiovascular diseases.

We are incredibly grateful to CNBC Indonesia for this opportunity to share our vision for the future of healthcare, and we look forward to engaging in more conversations like this! 🙌